Source: Program and Proceedings. Conference titles: Conference on Pancreatic Cancer: Advances in Science and Clinical Care. Unidade: FMRP
Subjects: PANCREATITE, NEOPLASIAS, NEOPLASIAS DO SISTEMA DIGESTÓRIO
ABNT
SILVEIRA, Vanessa da Silva et al. CRISPR screen identifies DUSP11 as a regulator of gemcitabine response in pancreatic carcinoma cell lines. 2018, Anais.. Boston: AACR, 2018. . Acesso em: 07 out. 2024.APA
Silveira, V. da S., Santos, V. S., Vieira, G. M., & Andrade, P. V. de. (2018). CRISPR screen identifies DUSP11 as a regulator of gemcitabine response in pancreatic carcinoma cell lines. In Program and Proceedings. Boston: AACR.NLM
Silveira V da S, Santos VS, Vieira GM, Andrade PV de. CRISPR screen identifies DUSP11 as a regulator of gemcitabine response in pancreatic carcinoma cell lines. Program and Proceedings. 2018 ;[citado 2024 out. 07 ]Vancouver
Silveira V da S, Santos VS, Vieira GM, Andrade PV de. CRISPR screen identifies DUSP11 as a regulator of gemcitabine response in pancreatic carcinoma cell lines. Program and Proceedings. 2018 ;[citado 2024 out. 07 ]